Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

Critical Remarks to Kloosterboer et al. June 2018

Zweipfenning, Peter G. M., MPharm

Therapeutic Drug Monitoring: December 2018 - Volume 40 - Issue 6 - p 761
doi: 10.1097/FTD.0000000000000559
Letters to the Editor

Foundation for Quality Control of Clinical Medicine Analysis and Toxicology/Dutch Foundation for Quality Assessment in Medical Laboratories, The Hague, the Netherlands

The author declares no conflict of interest.

Received March 19, 2018

Accepted June 04, 2018

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.